Literature DB >> 20036020

Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study.

Laurence Bal1, Stéphane Ederhy1, Emanuele Di Angelantonio1, Florence Toti2, Fatiha Zobairi2, Ghislaine Dufaitre1, Catherine Meuleman1, Ziad Mallat3, Franck Boccara1, Alain Tedgui3, Jean Marie Freyssinet2, Ariel Cohen4.   

Abstract

We investigated whether circulating procoagulant microparticles (CPMPs) contributed to hypercoagulability in 45 patients with acute pulmonary embolism (APE) and in 45 controls with and 45 controls without cardiovascular risk factors. Concentrations of CPMPs and platelet-derived microparticles (PMPs) were statistically significantly higher in patients with APE than in controls without cardiovascular risk factors. PMPs appeared to be the main source of procoagulant microparticle release in APE, but this correlation disappeared when APE patients were compared to controls with cardiovascular risk factors. CPMPs may have a role in venous thrombosis as mediators of cardiovascular risk factors.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2009        PMID： 20036020     DOI： 10.1016/j.ijcard.2009.11.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

2.  Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension.

Authors:  Philipp Diehl; Miriam Aleker; Thomas Helbing; Verena Sossong; Martin Germann; Stephan Sorichter; Christoph Bode; Martin Moser
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

3.  Effect of lower-leg trauma and knee arthroscopy on procoagulant phospholipid-dependent activity.

Authors:  Carolina E Touw; Banne Nemeth; Willem M Lijfering; Raymond A van Adrichem; Line Wilsgård; Nadezhda Latysheva; Cathrine Ramberg; Rob G H H Nelissen; John-Bjarne Hansen; Suzanne C Cannegieter
Journal:  Res Pract Thromb Haemost       Date:  2022-06-08

Review 4.  Coagulation and the vessel wall in pulmonary embolism.

Authors:  Sherin Alias; Irene M Lang
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 5.  Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.

Authors:  Bence György; Tamás G Szabó; Mária Pásztói; Zsuzsanna Pál; Petra Misják; Borbála Aradi; Valéria László; Eva Pállinger; Erna Pap; Agnes Kittel; György Nagy; András Falus; Edit I Buzás
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 6.  Platelet-Derived Microvesicles in Cardiovascular Diseases.

Authors:  Maria T K Zaldivia; James D McFadyen; Bock Lim; Xiaowei Wang; Karlheinz Peter
Journal:  Front Cardiovasc Med       Date:  2017-11-21

Review 7.  From Classical Laboratory Parameters to Novel Biomarkers for the Diagnosis of Venous Thrombosis.

Authors:  Larisa Anghel; Radu Sascău; Rodica Radu; Cristian Stătescu
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

Review 8.  Pathophysiology of Coagulation and Emerging Roles for Extracellular Vesicles in Coagulation Cascades and Disorders.

Authors:  Houssam Al-Koussa; Ibrahim AlZaim; Marwan E El-Sabban
Journal:  J Clin Med       Date:  2022-08-22       Impact factor: 4.964
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.